Startup · $31.6m raised
Melbourne, VIC
Every investor coverage indicates participated in a round Prota Therapeutics raised.
| Investor | Rounds | Invested |
|---|---|---|
| SPRIM Global Investments | Series A | - |
Companies Prota Therapeutics acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Prota Therapeutics. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Roundup of January 2024 funding: Futurerent, Prota Therapeutics, National Renewable Network and Getmee together secured $94.5 million across debt, equity and a government grant, with investor details for each deal.
Prota Therapeutics, a Melbourne biotech, has secured $32 million in equity and debt ahead of a Phase 3 trial of its peanut allergy therapy, with Singapore's SPRIM Global Investments leading the round.
Also SmartCompany·SmartCompany·SmartCompany·Business News Australia·Forbes Australia
Techboard's March 2022 roundup of Australian funding: megadeals by Immutable, Saluda Medical, Linktree and Zeller, many smaller raises, acquisitions, an IPO, several fund closes, and companies still seeking capital.
Also Australian FinTech